Inventor · disambiguated record
Jiangmei Li
Also filed as: LI JIANGMEI
14 granted patents·5 pending applications·63 citations·filing 2019–2024
89Inventor score
Top patents by PatentIndex Score
19 records- 0195US10421817B1Antibodies binding human Claudin 18.2 and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted Sep 24, 2019·33 cites·19 claims
- 0294US10570210B1Antibodies binding CD40 and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted Feb 25, 2020·13 cites·19 claims
- 0392US10946092B1Antibodies binding LAG3 and methods of treatment using themBEIJING MABWORKS BIOTECH CO LTD·Filed 2020·Granted Mar 16, 2021·3 cites·20 claims
- 0488US10577424B1Antibodies binding VISTA and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted Mar 3, 2020·5 cites·19 claims
- 0588US10442866B1Antibodies binding OX40 and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted Oct 15, 2019·8 cites·19 claims
- 0682US10662249B1Antibodies targeting CD40 and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted May 26, 2020·1 cites·17 claims
- 0777US10654937B1CD40 specific antibodies and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted May 19, 2020·0 cites·17 claims
- 0877US10654939B1Antibodies specific to CD40 and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted May 19, 2020·0 cites·17 claims
- 0977US10647776B1Anti-CD40 antibodies and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted May 12, 2020·0 cites·17 claims
- 1073US12084520B2Antibodies binding BCMA and CD3 and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2023·Granted Sep 10, 2024·0 cites·20 claims
- 1173US10654938B1CD40 binding antibodies and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted May 19, 2020·0 cites·17 claims
- 1271US2024392042A1Antibodies binding cd3 and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2024·Application pending·0 cites
- 1366US11091558B2Anti-OX40 antibodies and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted Aug 17, 2021·0 cites·12 claims
- 1462US2023348629A1Bispecific molecules binding tigit and vegf and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 1558US2023348612A1Single-chain fragment variable comprising mutant light chain framework regionBEIJING MABWORKS BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 1657US11718674B2Antibodies binding PD-L1 and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2021·Granted Aug 8, 2023·0 cites·15 claims
- 1757US2024084027A1Antibodies binding cd40 and pd-l1 and uses thereofBEIJING MABWORKS CO LTD·Filed 2023·Application pending·0 cites
- 1853US2022396617A1Antibodies binding tigit and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 1952US12180280B2Antibodies binding human and monkey CD3 and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2021·Granted Dec 31, 2024·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Jiangmei Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →